Internal Medicine, Pulmonary Disease · Meridian, ID
NPI
1629117619
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2347 E Gala St
Meridian, ID, 83642
Phone (208) 323-3767
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
220 services
Medicare patients, 2024
124
Average age 73
Drug cost, 2024
$5.8M
1,731 prescriptions
Company payments, 2025
$487
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen S Miller was code 99213 (office e&m - established), 53 times for 47 patients. In total Karen S Miller billed 220 services in 10 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 53 | 47 | $42.82 | $2,270 |
| 99214 Office E&M - Established | Office | 47 | 39 | $62.34 | $2,930 |
| 99204 Office E&M - New | Office | 28 | 28 | $92.02 | $2,576 |
| 99215 Office E&M - Established | Office | 27 | 20 | $93.61 | $2,528 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 25 | 11 | $21.92 | $548 |
By year: 2022 $11K for 168 services; 2023 $12K for 216 services; 2024 $12K for 220 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen S Miller prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 180 prescriptions and refills. In total Karen S Miller wrote 1,731 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 180 | 240 | 33 | $150K |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 119 | 122 | 12 | $3.1M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 107 | 133 | 36 | $3,615 |
| Azithromycin Generic | 88 | 131 | 18 | $1,386 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 79 | 89 | 14 | $11K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 75 | 97 | 23 | $8,585 |
| Breo Ellipta Fluticasone/Vilanterol | 73 | 79 | 11 | $30K |
| Spiriva Respimat Tiotropium Bromide | 70 | 78 | 14 | $39K |
| Famotidine Generic | 67 | 87 | 15 | $854 |
| Omeprazole Generic | 62 | 98 | 12 | $612 |
| Ofev Nintedanib Esylate | 56 | 56 | Under 11 | $721K |
| Prednisone Generic | 50 | 58 | 24 | $119 |
| Montelukast Sodium Generic | 43 | 96 | 12 | $748 |
| Arnuity Ellipta Fluticasone Furoate | 42 | 48 | Under 11 | $11K |
| Fluticasone Propionate Generic | 40 | 71 | 15 | $399 |
Brand drugs: 1,092 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen S Miller $487 ($487 in general payments such as food, travel and fees) from 7 companies. The largest payer was Insmed, Inc. with $207.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.